➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Moodys
AstraZeneca
Dow
Baxter

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Rubidium chloride rb-82 - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for rubidium chloride rb-82 and what is the scope of patent protection?

Rubidium chloride rb-82 is the generic ingredient in two branded drugs marketed by Bracco and Jubilant Draximage, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for rubidium chloride rb-82. Two suppliers are listed for this compound.

Summary for rubidium chloride rb-82
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 3
Suppliers / Packagers: 2
DailyMed Link:rubidium chloride rb-82 at DailyMed
Pharmacology for rubidium chloride rb-82

US Patents and Regulatory Information for rubidium chloride rb-82

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989 RX No No   Start Trial   Start Trial   Start Trial
Jubilant Draximage RUBY-FILL rubidium chloride rb-82 SOLUTION;INTRAVENOUS 202153-001 Sep 30, 2016 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for rubidium chloride rb-82

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989   Start Trial   Start Trial
Bracco CARDIOGEN-82 rubidium chloride rb-82 INJECTABLE;INJECTION 019414-001 Dec 29, 1989   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Moodys
AstraZeneca
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.